Wells Fargo’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $61K | Buy |
|
|||||
2022
Q4 | $26.7K | Buy |
|
|||||
2022
Q3 | $18K | Buy |
|
|||||
2022
Q2 | $20K | Sell |
|
|||||
2022
Q1 | $32K | Sell |
|
|||||
2021
Q4 | $104K | Buy |
|
|||||
2021
Q3 | $189K | Sell |
|
|||||
2021
Q2 | $1.08M | Buy |
|
|||||
2021
Q1 | $1.35M | Buy |
|
|||||
2020
Q4 | $1.1M | Buy |
|
|||||
2020
Q3 | $682K | Sell |
|
|||||
2020
Q2 | $783K | Buy |
|
|||||
2020
Q1 | $163K | Buy |
|
|||||
2019
Q4 | $278K | Buy |
|
|||||
2019
Q3 | $127K | Buy |
|
|||||
2019
Q2 | $0 | Buy |
|